Andreas Traschutz
Overview
    Explore the profile of Andreas Traschutz including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              51
            
            
              Citations
              705
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Beichert L, Seemann J, Kessler C, Traschutz A, Muller D, Dillmann-Jehn K, et al.
  
  
    Neurology
    . 2024 Dec;
          103(12):e209887.
    
    PMID: 39621946
  
  
          Background And Objectives: With targeted treatment trials on the horizon, identification of sensitive and valid outcome measures becomes a priority for >100 spastic ataxias. While digital-motor measures, assessed using wearable...
      
2.
        
    
    Hamdan A, Hendrickx N, Hooker A, Chen X, Comets E, Traschutz A, et al.
  
  
    Clin Pharmacol Ther
    . 2024 Oct;
          116(6):1593-1605.
    
    PMID: 39403821
  
  
          Degenerative cerebellar ataxias comprise a heterogeneous group of rare and ultra-rare genetic diseases. While disease-modifying treatments are now on the horizon for many ataxias, robust trial designs and analysis methods...
      
3.
        
    
    Tunca C, Islek Camadan E, Smolina N, Palvadeau R, Oztop Cakmak O, Vural A, et al.
  
  
    Mov Disord
    . 2024 Sep;
          39(12):2291-2297.
    
    PMID: 39314081
  
  
          Background: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is a common recessive ataxia that is still underdiagnosed worldwide. An easily accessible diagnostic biomarker might help to diagnostically confirm patients presenting...
      
4.
        
    
    Pellerin D, Seemann J, Traschutz A, Brais B, Ilg W, Synofzik M
  
  
    Mov Disord
    . 2024 Jul;
          39(10):1892-1894.
    
    PMID: 38949032
  
  
          No abstract available.
      
5.
        
    
    Beichert L, Ilg W, Kessler C, Traschutz A, Reich S, Santorelli F, et al.
  
  
    Mov Disord
    . 2024 Jun;
          39(9):1544-1555.
    
    PMID: 38847438
  
  
          Background: With treatment trials on the horizon, this study aimed to identify candidate digital-motor gait outcomes for autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), capturable by wearable sensors with multicenter...
      
6.
        
    
    Scaravilli A, Negroni D, Senatore C, Ugga L, Cosottini M, Ricca I, et al.
  
  
    Mov Disord
    . 2024 Jun;
          39(8):1343-1351.
    
    PMID: 38847051
  
  
          Background: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) and hereditary spastic paraplegia type 7 (SPG7) represent the most common genotypes of spastic ataxia (SPAX). To date, their magnetic resonance imaging...
      
7.
        
    
    Hendrickx N, Mentre F, Traschutz A, Gagnon C, Schule R, Synofzik M, et al.
  
  
    AAPS J
    . 2024 May;
          26(4):62.
    
    PMID: 38789847
  
  
          No abstract available.
      
8.
        
    
    Hamdan A, Hooker A, Chen X, Traschutz A, Schule R, Synofzik M, et al.
  
  
    CPT Pharmacometrics Syst Pharmacol
    . 2024 May;
          13(8):1327-1340.
    
    PMID: 38769902
  
  
          The Scale for the Assessment and Rating of Ataxia (SARA) is widely used for assessing the severity and progression of genetic cerebellar ataxias. SARA is now considered a primary end...
      
9.
        
    
    Hendrickx N, Mentre F, Traschutz A, Gagnon C, Schule R, Synofzik M, et al.
  
  
    AAPS J
    . 2024 Apr;
          26(3):57.
    
    PMID: 38689016
  
  
          The aim of this study was to develop a model to predict individual subject disease trajectories including parameter uncertainty and accounting for missing data in rare neurological diseases, showcased by...
      
10.
        
    
    Hermle D, Schubert R, Barallon P, Ilg W, Schule R, Reilmann R, et al.
  
  
    Ann Clin Transl Neurol
    . 2024 Apr;
          11(5):1097-1109.
    
    PMID: 38590028
  
  
          Objective: Voluntary upper limb movements are an ecologically important yet insufficiently explored digital-motor outcome domain for trials in degenerative ataxia. We extended and validated the trial-ready quantitative motor assessment battery...